Tseng William W, Amini Behrang, Madewell John E
Department of Surgery, Division of Upper GI/General Surgery, Section of Surgical Oncology, University of Southern California, Los Angeles, California; Hoag Family Cancer Institute, Hoag Memorial Hospital Presbyterian, Newport Beach, California.
J Surg Oncol. 2015 Apr;111(5):641-5. doi: 10.1002/jso.23814. Epub 2014 Oct 16.
Despite optimal treatment, patients with soft tissue sarcoma are at risk for recurrence and therefore appropriate surveillance is critical. At minimum, regularly scheduled clinical assessments and chest X-rays are necessary. Consensus guidelines are available; however, surveillance strategies must be personalized based on the risk for recurrence and inherent disease biology. Further research is needed on a number of issues, including the impact of surveillance on clinical outcome and the utility of molecular surveillance.
尽管接受了最佳治疗，软组织肉瘤患者仍有复发风险，因此适当的监测至关重要。至少，定期进行临床评估和胸部X光检查是必要的。已有共识指南；然而，监测策略必须根据复发风险和疾病固有生物学特性进行个性化定制。在许多问题上还需要进一步研究，包括监测对临床结果的影响以及分子监测的效用。
